Evidence map›Paper›PMID 23755170›Full record

ArticlePloS one2013

Ketogenic diet improves core symptoms of autism in BTBR mice.

David N Ruskin, Julia Svedova, Jessica L Cote, Ursula Sandau, Jong M Rho, Masahito Kawamura, Detlev Boison, Susan A Masino

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02477904 (Ketogenic Diet Therapy for Autism Spectrum Disorder), which is not on this map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02477904 nacompletednot on this mapstarted 2015, after this paper: background citation

Ketogenic Diet Therapy for Autism Spectrum Disorder

TypeinterventionalSponsorShriners Hospitals for ChildrenRan2015 to 2017Enrolled119ConditionsAutism Spectrum DisorderArmsKetogenic Diet
3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it, 175 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Modulation of pain by ketones: a mini-review.American journal of physiology. Cell physiology · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

David N RuskinNeuroscience Program, Trinity College, Hartford, Connecticut, United States of America.
Julia Svedova
Jessica L Cote
Ursula Sandau
Jong M Rho
Masahito Kawamura
Detlev Boison
Susan A Masino
Trinity College · USLegacy Health · USAlberta Children's Hospital · CAHartford Financial Services (United States)Jikei University School of Medicine · JP

Funding

Bladder, Urethra and Anal Sphincter ReinnervationR01NS070267 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI BARBE, MARY F · 2010 to 2024
$8.2M
The Role of Adenosine in Ketogenic Diet TherapyR01NS065957 · NINDS · TRINITY COLLEGE · PI BOISON, DETLEV, GEIGER, JONATHAN DAVID · 2010 to 2021
$3.9M
Astrocyte dysfunction in epileptogenesis: the role of adenosineR01NS061844 · NINDS · LEGACY EMANUEL HOSPITAL AND HEALTH CENTER · PI BOISON, DETLEV · 2009 to 2013
$1.5M
Ketogentic diet-induced changes in the cerebrospinal fluid: biomarkers and mechanismsR15NS066392 · NINDS · TRINITY COLLEGE · PI MASINO, SUSAN A · 2010 to 2015
$583k
NINDS NIH HHS R01 NS061844NINDS NIH HHS R01 NS065957NINDS NIH HHS R01 NS070267NINDS NIH HHS R15 NS066392
6 · The paper itself

Abstract

Autism spectrum disorders share three core symptoms: impaired sociability, repetitive behaviors and communication deficits. Incidence is rising, and current treatments are inadequate. Seizures are a common comorbidity, and since the 1920's a high-fat, low-carbohydrate ketogenic diet has been used to treat epilepsy. Evidence suggests the ketogenic diet and analogous metabolic approaches may benefit diverse neurological disorders. Here we show that a ketogenic diet improves autistic behaviors in the BTBR mouse. Juvenile BTBR mice were fed standard or ketogenic diet for three weeks and tested for sociability, self-directed repetitive behavior, and communication. In separate experiments, spontaneous intrahippocampal EEGs and tests of seizure susceptibility (6 Hz corneal stimulation, flurothyl, SKF83822, pentylenetetrazole) were compared between BTBR and control (C57Bl/6) mice. Ketogenic diet-fed BTBR mice showed increased sociability in a three-chamber test, decreased self-directed repetitive behavior, and improved social communication of a food preference. Although seizures are a common comorbidity with autism, BTBR mice fed a standard diet exhibit neither spontaneous seizures nor abnormal EEG, and have increased seizure susceptibility in just one of four tests. Thus, behavioral improvements are dissociable from any antiseizure effect. Our results suggest that a ketogenic diet improves multiple autistic behaviors in the BTBR mouse model. Therefore, ketogenic diets or analogous metabolic strategies may offer novel opportunities to improve core behavioral symptoms of autism spectrum disorders.

Indexed as

Diet, KetogenicAnimalsAutistic DisorderBenzazepinesBrain WavesCA3 Region, HippocampalCerebral CortexHumansMaleMice, Inbred C57BLSeizures3-allyl-6-chloro-7,8-dihydroxy-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepineBenzazepines

Identifiers

PMID23755170
PMCPMC3673987
OpenAlexW2067213832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.